{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:11:48Z","timestamp":1768734708270,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P24946"],"award-info":[{"award-number":["P24946"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bcp.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T03:26:57Z","timestamp":1533871617000},"page":"168-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Modulation of nitric oxide-stimulated soluble guanylyl cyclase activity by cytoskeleton-associated proteins in vascular smooth muscle"],"prefix":"10.1016","volume":"156","author":[{"given":"Alexander","family":"Kollau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Gesslbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Russwurm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Koesling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonius C.F.","family":"Gorren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Schrammel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.08.009_b0005","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1073\/pnas.74.8.3203","article-title":"Nitric oxide activates guanylate cyclase and increases guanosine 3\u0301:5\u0301-cyclic monophosphate levels in various tissue preparations","volume":"74","author":"Arnold","year":"1977","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.08.009_b0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3565(25)32738-2","article-title":"Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates","volume":"218","author":"Ignarro","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2018.08.009_b0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.niox.2009.07.004","article-title":"The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models","volume":"21","author":"Friebe","year":"2009","journal-title":"Nitric Oxide Biol. Chem."},{"key":"10.1016\/j.bcp.2018.08.009_b0020","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2018.08.009_b0025","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2018.08.009_b0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.bcp.2018.08.009_b0035","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1002\/j.1460-2075.1996.tb01078.x","article-title":"Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme","volume":"15","author":"Friebe","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2018.08.009_b0040","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V84.12.4226.bloodjournal84124226","article-title":"YC-1, a novel activator of platelet guanylate cyclase","volume":"84","author":"Ko","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.08.009_b0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/cmdc.200900014","article-title":"Discovery of riociguat (BAY 63\u20132521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension","volume":"4","author":"Mittendorf","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bcp.2018.08.009_b0050","doi-asserted-by":"crossref","first-page":"H792","DOI":"10.1152\/ajpheart.00953.2010","article-title":"Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60\u20132770, are not dependent on endogenous nitric oxide or reduced heme","volume":"300","author":"Pankey","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2018.08.009_b0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1476-5381.2009.00263.x","article-title":"Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation","volume":"157","author":"Hoffmann","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.009_b0060","series-title":"Nitric Oxide: Biology and Pathobiology","first-page":"301","article-title":"Soluble guanylate cyclase: allosteric activation and redox regulation","author":"Hobbs","year":"2010"},{"key":"10.1016\/j.bcp.2018.08.009_b0065","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1074\/jbc.M411545200","article-title":"Characterization of a novel type of endogenous activator of soluble guanylyl cyclase","volume":"280","author":"Balashova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.08.009_b0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/ars.2016.6690","article-title":"Regulation of sGC via hsp90, cellular heme, sGC agonists, and NO: New pathways and clinical perspectives","volume":"26","author":"Ghosh","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.08.009_b0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.niox.2016.01.005","article-title":"Scavenging of nitric oxide by hemoglobin in the tunica media of porcine coronary arteries","volume":"54","author":"Kollau","year":"2016","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2018.08.009_b0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0076-6879(05)96041-2","article-title":"Purification and characterization of NO-sensitive guanylyl cyclase","volume":"396","author":"Russwurm","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bcp.2018.08.009_b0085","series-title":"Methods of Enzymatic Analysis","first-page":"379","article-title":"Guanylate cyclase. GTP pyrophosphate-lyase (cyclizing), E.C.4.6.1.2","author":"Schultz","year":"1984"},{"key":"10.1016\/j.bcp.2018.08.009_b0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1432-1033.1996.0380h.x","article-title":"A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha(1) and beta(1) subunits","volume":"240","author":"Foerster","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2018.08.009_b0095","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2018.08.009_b0100","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","article-title":"Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein","volume":"4","author":"Ishihama","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bcp.2018.08.009_b0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/mol.117.109918","article-title":"Irreversible activation and stabilization of soluble guanylate yyclase by the protoporphyrin IX mimetic cinaciguat","volume":"93","author":"Kollau","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.009_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)09113-8","article-title":"Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as heme-site inhibitor of nitric oxide sensitive guanylyl cyclase","volume":"50","author":"Schrammel","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.009_b0115","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","article-title":"NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle","volume":"136","author":"Stasch","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.009_b0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-62703-538-5_9","article-title":"Cytoplasmic actin: purification and single molecule assembly assays","volume":"1046","author":"Hansen","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2018.08.009_b0125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/pr.115.010652","article-title":"Mechanisms of vascular smooth muscle contraction and the basis for pharmakologic treatment of smooth muscle disorders","volume":"68","author":"Brozovich","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2018.08.009_b0130","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/S0006-3495(98)77751-3","article-title":"Ca2+ regulation of gelsolin activity: binding and severing of F-actin","volume":"75","author":"Kinosian","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.bcp.2018.08.009_b0135","doi-asserted-by":"crossref","first-page":"33179","DOI":"10.1074\/jbc.274.47.33179","article-title":"Gelsolin, a multifunctional actin regulatory protein","volume":"274","author":"Sun","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.08.009_b0140","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/cm.21149","article-title":"The expanding superfamily of gelsolin homolgy domain proteins","volume":"70","author":"Ghoshdastider","year":"2013","journal-title":"Cytoskeleton"},{"key":"10.1016\/j.bcp.2018.08.009_b0145","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1242\/jcs.01245","article-title":"Annexins \u2013 unique membrane binding proteins with diverse functions","volume":"117","author":"Rescher","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2018.08.009_b0150","first-page":"935","article-title":"Annexin A6 - linking Ca2+ signaling with cholesterol transport","volume":"1813","author":"Enrich","year":"2011","journal-title":"BBA"},{"key":"10.1016\/j.bcp.2018.08.009_b0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF00169010","article-title":"Characterization of soluble platelet guanylyl cyclase with peptide antibodies","volume":"346","author":"Guthmann","year":"1992","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.009_b0160","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI27657","article-title":"Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system","volume":"116","author":"Mergia","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2018.08.009_b0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1432-1033.1990.tb15572.x","article-title":"Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method","volume":"190","author":"Humbert","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2018.08.009_b0170","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1055\/s-0038-1649694","article-title":"The platelet cytoskeleton","volume":"70","author":"Fox","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcp.2018.08.009_b0175","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1242\/jcs.044537","article-title":"Differential VASP phosphorylation controls remodeling of the actin cytoskeleton","volume":"122","author":"Benz","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2018.08.009_b0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/1097-0169(200012)47:4<351::AID-CM8>3.0.CO;2-8","article-title":"VASP protects actin filaments from gelsolin: an in vitro study with implications for platelet actin reorganizations","volume":"47","author":"Bearer","year":"2000","journal-title":"Cell Motil. Cytoskeleton."},{"key":"10.1016\/j.bcp.2018.08.009_b0185","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1111\/j.1742-4658.2008.06654.x","article-title":"S100-annexin complexes \u2013 structural insights","volume":"275","author":"Rintala-Dempsey","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2018.08.009_b0190","doi-asserted-by":"crossref","first-page":"C1417","DOI":"10.1152\/ajpcell.00439.2006","article-title":"Identification of a novel ineraction between the Ca2+-binding protein S100A11 and the Ca2+- and phospholipid-binding protein annexin A6","volume":"292","author":"Chang","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2018.08.009_b0195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jemt.10296","article-title":"Intracellular and extracellular roles of S100 proteins","volume":"60","author":"Donato","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.bcp.2018.08.009_b0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20060195","article-title":"Calcium-dependent and -independent interactions of the S100 protein family","volume":"396","author":"Santamaria-Kisiel","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2018.08.009_b0205","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0960-894X(01)00073-7","article-title":"NO-independent stimulators of soluble guanylate cyclase","volume":"11","author":"Straub","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2018.08.009_b0210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","article-title":"NO-independent regulatory site on soluble guanylate cyclase","volume":"410","author":"Stasch","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.08.009_b0215","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.biochem.7b01240","article-title":"Mechanistic insights into the activation of soluble guanylate cyclase by carbon monoxide: A multistep mechanism proposed for the BAY 41\u20132272 induced formation of 5-coordinate CO-heme","volume":"57","author":"Makino","year":"2018","journal-title":"Biochemistry"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218303290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218303290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T08:28:16Z","timestamp":1751790496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218303290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":43,"alternative-id":["S0006295218303290"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.08.009","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of nitric oxide-stimulated soluble guanylyl cyclase activity by cytoskeleton-associated proteins in vascular smooth muscle","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}